here is a well-documented association between ADHD, related behavioral disorders, and low levels of omega-3 fatty acids. One study published in Prostaglandins, Leukotrienes and Essential Fatty Acids (Volume 75, Issues 4–5, October–November 2006, Pages 299–308) examined essential fatty acid status in individuals newly diagnosed with ADHD.
The researchers measured omega-3 fatty acid levels in red blood cell membranes and plasma phospholipids, which are considered reliable indicators of longer-term fatty acid status. Importantly, the subjects with ADHD were newly diagnosed and not taking stimulant medication, eliminating medication effects as a confounding factor.
Symptoms commonly associated with essential fatty acid deficiency—such as dry skin and excessive thirst—were more prevalent in the ADHD group than in healthy controls. Follow-up testing included blood and urine analysis, dietary intake assessment, and completion of general health questionnaires.
The results showed that individuals with ADHD had significantly lower omega-3 fatty acid levels in both red blood cells and plasma phospholipids compared to controls. At the same time, dietary analysis revealed that the ADHD group consumed approximately 30% more saturated fat than the control group.
The researchers were unable to determine whether the low omega-3 levels were due to reduced intake, altered metabolism, impaired absorption, or increased utilization. They concluded that further research was warranted to better understand the relationship between fatty acid status, diet composition, and behavioral symptoms in ADHD.
Taken together, these findings suggest that imbalances in dietary fat intake—particularly low omega-3 intake combined with higher saturated fat consumption—may be relevant to ADHD physiology, and deserve continued investigation.
